Home › Stocks › AVLN

AVLN — AVALYN PHARMACEUTICALS INC

Reported value held$1.46B
Funds holding (latest)122
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)94
Institutional value$1.47B · 44.59M sh
New / Add / Cut / Exit94 / 0 / 0 / 0 · Updated 2026-11-14
Top-5 / Top-10 concentration40.8% / 62.1%

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 94 SEC-registered investment managers reported holding AVLN (AVALYN PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $1.47B across 44.59M shares. Ownership is concentrated: the five largest holders account for 40.8% of reported value and the top ten for 62.1%.

Compared with the prior quarter, 94 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

Major shareholders of AVALYN PHARMACEUTICALS INC (AVLN) include Fidelity Management & Research (FMR), Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, ranked by reported 13F value among the 122 institutional holders on this page.

AVLN is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 60 16.84M $479.36M +6.3%
Q2 2026 94 44.59M $1.47B —
Q1 2024 1 1.00K $4.72K -50.0%
Q4 2023 1 2.00K $8.39K +0.0%
Q3 2023 1 2.00K $4.20K —

Over the 5 quarters shown, institutional share counts increased 842031% in aggregate (Q3 2023 → Q3 2026); the largest single-quarter swing was Q1 2024 (-50.0%).

Top Institutional Holders (Q3 2026) — 25 funds

FundSharesValuePortfolio WeightChange
Fidelity Management & Research (FMR) 6.19M $176.24M 0.01% Add
NVP Associates, LLC history 2.27M $64.63M 22.92% Hold
EVENTIDE ASSET MANAGEMENT, LLC 1.38M $39.19M 0.55% Hold
BlackRock Inc 1.33M $37.75M 0.00% Add
Andera Partners history 929.82K $26.49M 15.08% Hold
Pivotal bioVenture Partners Investment Advisor LLC history 866.79K $24.69M 10.06% Reduce
VANGUARD CAPITAL MANAGEMENT LLC 752.82K $21.45M 0.00% Add
STATE STREET CORP 554.00K $15.78M 0.00% New
Geode Capital Management 471.06K $13.42M 0.00% Add
SILVERARC CAPITAL MANAGEMENT, LLC history 378.35K $10.78M 1.37% Add
Franklin Resources 331.68K $9.11M 0.00% Hold
UBS Group AG 189.25K $5.39M 0.00% Add
FEDERATED HERMES, INC. 160.00K $4.56M 0.01% Hold
Jones Hill Capital LP history 126.74K $3.61M 0.61% New
VANGUARD PORTFOLIO MANAGEMENT LLC 125.80K $3.58M 0.00% Add
VANGUARD FIDUCIARY TRUST CO 122.93K $3.50M 0.00% Add
Manulife Financial 95.56K $2.72M 0.00% New
TD ASSET MANAGEMENT INC 98.18K $2.66M 0.00% Add
Walleye Capital LLC 54.58K $1.56M 0.01% New
Quadrature Capital Ltd 47.47K $1.35M 0.01% New
Quantinno Capital Management LP 47.12K $1.34M 0.00% New
BNY Mellon 44.04K $1.25M 0.00% Add
Morgan Stanley 32.25K $918.69K 0.00% Add
Swiss National Bank 31.40K $894.59K 0.00% New
Nuveen, LLC 31.25K $890.28K 0.00% Add

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 25 funds

FundSharesValuePortfolio WeightChange
Fidelity Management & Research (FMR) 5.84M $192.10M 0.01% New
Novo Holdings A/S history 3.88M $127.84M 7.42% New
SR ONE CAPITAL MANAGEMENT, LP history 3.31M $108.92M 10.48% New
PERCEPTIVE ADVISORS LLC history 2.68M $88.07M 1.40% New
MONTANOVA CAPITAL, LLC history 2.50M $82.40M 1.51% New
NVP Associates, LLC history 2.27M $74.68M 22.75% New
WELLINGTON MANAGEMENT GROUP LLP 2.20M $72.49M 0.01% New
PRICE T ROWE ASSOCIATES INC /MD/ 1.74M $57.12M 0.01% New
Catalio Capital Management, LP history 1.68M $55.17M 10.37% New
T. Rowe Price Investment Management, Inc. 1.60M $52.76M 0.04% New
EVENTIDE ASSET MANAGEMENT, LLC 1.38M $45.28M 0.60% New
Bellevue Group AG history 1.35M $44.44M 0.94% New
BlackRock Inc 977.26K $32.17M 0.00% New
Pivotal bioVenture Partners Investment Advisor LLC history 966.79K $31.83M 10.34% New
Citadel Advisors 959.10K $31.57M 0.04% New
Andera Partners history 929.82K $30.61M 14.82% New
JENNISON ASSOCIATES LLC 812.75K $26.76M 0.02% New
BRAIDWELL LP history 801.39K $26.38M 1.04% New
TPG GP A, LLC history 773.07K $25.45M 0.52% New
VANGUARD CAPITAL MANAGEMENT LLC 739.77K $24.35M 0.00% New
DEERFIELD MANAGEMENT COMPANY, L.P. 731.00K $24.06M 0.30% New
Rock Springs Capital Management LP history 662.92K $21.82M 1.06% New
GEODE CAPITAL MANAGEMENT, LLC 434.65K $14.31M 0.00% New
Geode Capital Management 434.65K $14.31M 0.00% New
Soleus Capital Management, L.P. history 419.00K $13.79M 0.47% New

Q1 2024 — 1 funds

FundSharesValuePortfolio WeightChange
Heritage Wealth Advisors 1.00K $4.72K 0.00% Reduce

Q4 2023 — 1 funds

FundSharesValuePortfolio WeightChange
Heritage Wealth Advisors 2.00K $8.39K 0.00% Hold

Q3 2023 — 1 funds

FundSharesValuePortfolio WeightChange
Heritage Wealth Advisors 2.00K $4.20K 0.00% New

View all 122 fund holders →

New Positions (Q2 2026)

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2024Q4 2023Q3 2023
Fidelity Management & Research (FMR) 6.19M 5.84M — — —
NVP Associates, LLC 2.27M 2.27M — — —
EVENTIDE ASSET MANAGEMENT, LLC 1.38M 1.38M — — —
BlackRock Inc 1.33M 977.26K — — —
Andera Partners 929.82K 929.82K — — —
Pivotal bioVenture Partners Investment Advisor LLC 866.79K 966.79K — — —
VANGUARD CAPITAL MANAGEMENT LLC 752.82K 739.77K — — —
STATE STREET CORP 554.00K — — — —
Geode Capital Management 471.06K 434.65K — — —
SILVERARC CAPITAL MANAGEMENT, LLC 378.35K 330.49K — — —
Franklin Resources 331.68K 331.68K — — —
UBS Group AG 189.25K 12.30K — — —
FEDERATED HERMES, INC. 160.00K 160.00K — — —
Jones Hill Capital LP 126.74K — — — —
VANGUARD PORTFOLIO MANAGEMENT LLC 125.80K 117.34K — — —
VANGUARD FIDUCIARY TRUST CO 122.93K 116.76K — — —
Manulife Financial 95.56K — — — —
TD ASSET MANAGEMENT INC 98.18K 94.64K — — —
Walleye Capital LLC 54.58K — — — —
Quadrature Capital Ltd 47.47K — — — —

Download holders (CSV)

FAQ

Which funds hold AVLN?

As of 2026-Q2, 94 institutional funds reported holding AVLN (AVALYN PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $1.47B.

How many shares of AVLN do institutions own?

13F filers reported 44.59M shares of AVLN, worth $1.47B in aggregate at the end of 2026-Q2.

Is institutional ownership of AVLN rising or falling?

No prior-quarter baseline is available for a directional read.

Who are the top institutional holders of AVLN?

The largest 13F holders are Fidelity Management & Research (FMR), Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, MONTANOVA CAPITAL, LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of AVALYN PHARMACEUTICALS INC?

The major shareholders of AVALYN PHARMACEUTICALS INC (AVLN) by reported 13F value are Fidelity Management & Research (FMR), Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, MONTANOVA CAPITAL, LLC, among 122 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own AVLN" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/AVLN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →